11252686

Source:http://linkedlifedata.com/resource/pubmed/id/11252686

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0012091, umls-concept:C0022742, umls-concept:C0029408, umls-concept:C0538927, umls-concept:C1273870
pubmed:issue	1
pubmed:dateCreated	2001-3-16
pubmed:abstractText	A clinical trial was conducted in 600 patients with OA of the knee to test the hypothesis that the specific COX-2 inhibitor, celecoxib, has equivalent efficacy and a superior tolerability/safety profile when compared to diclofenac, the current worldwide standard of care.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0321213
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Diclofenac, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins, http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/celecoxib
pubmed:status	MEDLINE
pubmed:issn	0300-9742
pubmed:author	pubmed-author:BorensteinDD, pubmed-author:GeisG SGS, pubmed-author:LefkowithJ BJB, pubmed-author:McKennaFF, pubmed-author:WallemarkCC, pubmed-author:WendtHH
pubmed:issnType	Print
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	11-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11252686-Activities of Daily Living, pubmed-meshheading:11252686-Adult, pubmed-meshheading:11252686-Aged, pubmed-meshheading:11252686-Aged, 80 and over, pubmed-meshheading:11252686-Alanine Transaminase, pubmed-meshheading:11252686-Aspartate Aminotransferases, pubmed-meshheading:11252686-Creatinine, pubmed-meshheading:11252686-Cyclooxygenase Inhibitors, pubmed-meshheading:11252686-Diclofenac, pubmed-meshheading:11252686-Double-Blind Method, pubmed-meshheading:11252686-Female, pubmed-meshheading:11252686-Gastrointestinal Diseases, pubmed-meshheading:11252686-Hemoglobins, pubmed-meshheading:11252686-Humans, pubmed-meshheading:11252686-Knee Joint, pubmed-meshheading:11252686-Male, pubmed-meshheading:11252686-Middle Aged, pubmed-meshheading:11252686-Osteoarthritis, Knee, pubmed-meshheading:11252686-Pain Measurement, pubmed-meshheading:11252686-Pyrazoles, pubmed-meshheading:11252686-Severity of Illness Index, pubmed-meshheading:11252686-Sulfonamides, pubmed-meshheading:11252686-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Celecoxib versus diclofenac in the management of osteoarthritis of the knee.
pubmed:affiliation	Rheumatic Diseases Unit, Trafford General Hospital, Manchester, UK.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't